Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation

Transplant Immunology

Volumn 18, Issue 3, 2008, Pages 260-263

  Golocheikine, Anjali S ^a   Saini, Deepti ^a   Ramachandran, Sabarinathan ^a   Trulock, Elbert P ^a   Patterson, Alexander ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis obliterans syndrome (BOS); Chronic rejection; FEV1; Lung transplantation; sCD30

Indexed keywords

CD30 ANTIGEN;

ADULT; ALLOIMMUNITY; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD30; BRONCHIOLITIS OBLITERANS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 36348989633     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.07.007     Document Type: Article

References (19)

1. Fields R.C., Bharat A., Steward N., Aloush A., Meyers B.F., Trulock E.P., et al. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 82 12 (2006) 1596-1601
2. Boehler A., Kesten S., Weder W., and Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 114 (1998) 1411-1426
3. Morita K., Miura M., Paolone D.R., Engeman T.M., Kapoor A., Remich D.G., et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 167 5 (2001) 2979-2984
4. Girgis R.E., Tu I., Berry G.J., Reichenspurner H., Valentine V.G., Conte J.V., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 15 12 (1996) 1200-1208
5. Reznik S.I., Jaramillo A., SivaSai K.S.R., Womer K.L., Sayegh M.H., Trulock E.P., et al. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 1 (2001) 228-235
6. Jaramillo A., Fernandez F.G., Kuo E.Y., Trulock E.P., Patterson G.A., and Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 9 1 (2005) 84-93
7. Yousem S.A., Berry G.J., Cagle P.T., Chamberlain D., Husain A.N., and Hruban R.H. Revisions of the 1990 working formulation for the classification of pulmonary allograft. Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
8. Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299 5878 (1982) 65-67
9. Baraclay A.N., Birkeland M.L., Brown M.H., Beyers A.D., Davis S.J., Somoza C., et al. The leucocyte antigens facts book (1993), Academic, London, UK
10. Gross H.J., Boiani N., Williams D.E., Armitage R.J., Smith C.A., and Goodwin R.G. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83 8 (1994) 2045-2056
11. Josimovic-Alasevic O., Durkop H., Schwawrting R., Backe E., Stein H., and Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 19 1 (1989) 157-162
12. Wang D., Wu G.J., Wu W.Z., Yang S.L., Chen J.H., Wang H., et al. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection. Transpl Immunol 17 4 (2007) 278-282
13. Gerli R., Bistoni O., Lunardi C., Giacomelli R., Tomassini C., Biagini P., et al. Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology (Oxford) 38 12 (1999) 1282-1284
14. Tarkowski M. Expression and a role of CD30 in regulation of T-cell activity. Curr Opin Hematol 10 4 (2003) 267-271
15. Del Prete G., De Carli M., Almerigogna F., Daniel C.K., D'Elios M.M., Zancuoghi G., et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 9 1 (1995) 81-86
16. SivaSai K.S.R., Smith M.A., Poindexter N., Sundaresan R.S., Trulock E., Lynch J.P., et al. Indirect recognition of donor HLA class I peptides in lung transplantation recipients with bronchiolitis obliterans syndrome. Transplantation 67 (1999) 1094-1098
17. Lu K.C., Jaramillo A., Mendeloff E.N., Huddleston C.B., Sweet S.C., Patterson G.A., et al. Concomitant allorecognition of mismatched donor HLA class I- and II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 22 (2003) 35-43
18. Bharat A., Narayanan K., Street T., Fields R.C., Steward N., Aloush A., et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 83 2 (2007) 150-158
19. Bharat A., Fields R.C., Trulock E.P., Patterson G.A., and Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol 177 8 (2006) 5631-5638